Light therapy for abnormal cervical or vaginal cells
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a light-based treatment (photodynamic therapy) for high-grade or persistent low-grade abnormal cells in the cervix or vagina. It aims to destroy these cells without surgery, which may be an option for patients who want to avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-grade abnormal cells in the cervix (CIN2 or CIN3) or vagina (VaIN2 or VaIN3), confirmed by a biopsy.
- Or you have low-grade abnormal cells (CIN1 or VaIN1) that have lasted more than one year and you want treatment.
- Your doctor was able to see the area clearly during a colposcopy exam.
- A sample from your cervical canal did not show any higher-grade abnormal cells.
- You do not have cancer or any suspicion of cancer.
- You do not have porphyria (a blood disorder) or a known allergy to red or blue light.
- You do not have other serious medical conditions that could interfere with the treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a light-based treatment called photodynamic therapy for women with moderate to severe cervical changes (CIN3). It aims to destroy abnormal cells while saving healthy tissue.
This study tests a new light-based device to screen for cervical cancer. It is for people who already have abnormal screening results (like high-risk HPV and an abnormal Pap test).
This study tests a new light-based device to screen for cervical cancer. It may help find cancer earlier in people with certain HPV types or abnormal Pap tests.
This trial tests a light-activated therapy (called photodynamic therapy) using a special gel that is put on the skin and then activated with a light to treat moderate to severe acne. It may help people who have not responded well to other treatments.
This trial tests a light-activated drug (ALA-PDT) to treat low-grade cervical changes caused by HPV 16 or 18. It may help clear the virus and prevent progression to more serious disease.
This study tests a light-based treatment (photodynamic therapy) for cervical precancer called CIN2. It may be an option if you want to avoid surgery and preserve the cervix.
Hear when a new Precancerous Cervical Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.